This website is not optimized for your browser version. Update to the latest Internet Explorer Version for a safer and faster web experience
13th National Laser and Cosmetic Medicine Conference

13th National Laser and Cosmetic Medicine Conference 11 - 12 November 2017
Crown Promenade, Melbourne

Abstract Submission Details

Online Submissions Now Closed

Accepted abstracts will be included in the LCMC 2017 program.

  • Abstracts should be submitted using the abstract template. Click here to download.
  • Papers can only be presented by one presenter
  • Abstract title should be in BLOCK CAPITALS
  • Authors names should be on the next line
  • In case of more than one author please underline the name of the presenting author
  • Do not include degrees or titles
  • Authors' organizations/institutions should appear on the next line and should include the suburb/city, state and country of the organizations/institutions.

Themes to be considered

  • Dermal fillers for facial enhancement 
  • Diagnosis and management of skin cancer 
  • Facial rejuvenation techniques 
  • Fractioned laser technology 
  • Laser hair removal 
  • Laser theory and safety 
  • Intense pulsed light (IPL) 
  • Lasers for vascular / pigmented lesions 
  • Liposuction and liposculpture 
  • Medico-legal 
  • Non-surgical facial enhancement 
  • Photorejuvenation techniques 
  • Post treatment care 
  • Stems cells and anti-ageing medicine 
  • Strategies to optimise your cosmetic practice 
  • Techniques for skin reconditioning 
  • Ultrasound liposuction 
  • Use of botulinum toxin type A for facial rejuvenation 

Abstract Body Format

Must be 300 words or less, inclusive of title, author(s) names, and institutional affiliation(s) and references. Please do not use abbreviations unless defined in the abstract. All submissions should be in Microsoft Word format.

Content should include the following sections:

Background and Aims: Include one or two sentences to introduce the broad topic area and provide a reason for the study. Provide a clear statement of the aims of the study. A hypothesis could be included in this section It may also be appropriate to add references to cited literature here. References will be included in the word limit. Authors are advised to keep references to a minimum, and to use an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.

Methods: In this section information on participants (and /or subjects) should be provided. This may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Study inclusion and exclusion criteria should be included in this section as well as a sample size calculation if presenting a randomised clinical trial. Measures and procedures used in the study are described in this section. Descriptions of analyses appear in the methods section.

Results: The purpose of the result section is to provide a description of the main findings of the study. Reference to potential results that were unavailable at the time that the abstract was submitted will not be acceptable. Submitted abstracts must include actual results. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).

Conclusions: In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.

All abstracts will be reviewed by the abstract review committee within four weeks after the closing date.

All presenters must register for the conference by the Early Bird Deadline for registration (1 October 2017) or the presentation will be withdrawn from the program.